glp-1 peptide Glucagon-Like 1 | C149H226N40O45 | CID 16133831 Schematic representation of different GLP-1

ej., disautonoma, intolerancias, alteraciones gastrointestinales)

J Neurosci Res 79:509521 Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, Bested AC, Flor-Henry P, Joshi P, Powles ACP, Sherkey JA, van de Sande MI (2011) Myalgic encephalomyelitis/chronic fatigue syndrome

CJC-1295 CJC-1295 is another peptide that improves growth hormone release

Are there any safety concerns or contraindications for combining these peptides

Short-acting drugs primarily lower postprandial blood glucose levels by slowing gastric emptying, while long-acting GLP-1 RAs are more effective at reducing fasting blood glucose levels, mainly by promoting insulin secretion and inhibiting glucagon release

p = 0.02) (Wiberg et al., 2018)